Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320697 · ClinicalTrials.gov registry record · Phase 4
Smoking Relapse Prevention in Schizophrenia
A Phase 4 study, sponsored by North Suffolk Mental Health Association.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00320697: Completed Phase 4 study, sponsored by North Suffolk Mental Health Association.
NCT00320697 is a Phase 4 study that has completed, run by North Suffolk Mental Health Association. The registered enrollment target is 25 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00320697, a Phase 4 study, has completed, sponsored by North Suffolk Mental Health Association.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study seeks to determine if continued treatment with bupropion and nicotine replacement therapy (NRT) can reduce the smoking relapse rate in patients with schizophrenia.
Interventions
- DRUG bupropion + nicotine patch + nicotine gum or lozenges
- DRUG Placebo pill + placebo patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
What the finished NCT00320697 record still lists
NCT00320697 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which bupropion + nicotine patch + nicotine gum or lozenges is the first listed.
NCT00320697 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00320697 about?
NCT00320697 is a clinical study titled "Smoking Relapse Prevention in Schizophrenia". This study seeks to determine if continued treatment with bupropion and nicotine replacement therapy (NRT) can reduce the smoking relapse rate in patients with schizophrenia.
What is the current status of trial NCT00320697?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2006-04. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00320697?
The interventions under investigation include: bupropion + nicotine patch + nicotine gum or lozenges (DRUG), Placebo pill + placebo patch (DRUG).
Who is sponsoring clinical trial NCT00320697?
This trial is sponsored by North Suffolk Mental Health Association, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00320697's enrollment target sits among peer trials
25 1669th of 2000 higher than 302 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia